Showing results (971-980 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|June 18, 2009
CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The NetherlandsValère J Goossens, Petra F Wolffs, Inge H van Loo, et al.AIDS (London, England)|May 19, 2009
HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trialElizabeth M Stringer, Jens Levy, Moses Sinkala, et al.AIDS (London, England)|July 8, 2009
HIV sensitivity to neutralization is determined by target and virus producer cell propertiesAxel M Mann, Peter Rusert, Livia Berlinger, et al.AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.AIDS (London, England)|July 9, 2009
Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recoveryOlena Stepanyuk, Tom S Chiang, Lisa L Dever, et al.AIDS (London, England)|July 9, 2009
Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysisNicole Crepaz, Gary Marks, Adrian Liau, et al.AIDS (London, England)|June 25, 2009
HIV integration site distributions in resting and activated CD4+ T cells infected in cultureTroy Brady, Luis M Agosto, Nirav Malani, et al.AIDS (London, England)|January 1, 1990
HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathwayK E Nye, A J PinchingAIDS (London, England)|August 22, 2009
Renal function with use of a tenofovir-containing initial antiretroviral regimenJoel E Gallant, Richard D MooreAIDS (London, England)|July 24, 2009
Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled studyBirgitte R Hansen, Lilian Kolte, Steen B Haugaard, et al.Pageof 1,044